Home・Aktien・Embecta Corp

Embecta Corp

Geschlossen

BrancheGesundheitswesen

4.42 26.65

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.51

Max

4.68

Schlüsselkennzahlen
By Trading Economics
Einkommen	-48M -4.1M
Verkäufe	-39M 222M
KGV Branchendurchschnitt	1.928 68.51
EPS	0.27
Dividendenrendite	16.48
Gewinnspanne	-1.849
Angestellte	1,850
EBITDA	-51M 45M

Empfehlungen
By TipRanks
Empfehlungen	Sell
12-Monats-Prognose	-14.29% downside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	16.48% 2.29%
Nächstes Ergebnis	7. Aug. 2026
Nächste Dividendenausschüttung	15. Sept. 2026
Nächstes Ex-Dividendendatum	27. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-327M 221M
Vorheriger Eröffnungskurs	-22.23
Vorheriger Schlusskurs	4.42

Nachrichtenstimmung

By Acuity

72%

28%

308 / 340 Ranking in Healthcare

Embecta Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Aug. 2026, 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

5. Aug. 2026, 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

4. Aug. 2026, 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

3. Aug. 2026, 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

31. Juli 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

30. Juli 2026, 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

29. Juli 2026, 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

28. Juli 2026, 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

27. Juli 2026, 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

24. Juli 2026, 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

22. Juli 2026, 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

21. Juli 2026, 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

20. Juli 2026, 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Peer-Vergleich

Kursveränderung

Embecta Corp Prognose

Kursziel

By TipRanks

-14.29% Nachteil

12-Monats-Prognose

Durchschnitt 3 USD -14.29%

Hoch 3 USD

Tief 3 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Embecta Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Sell

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Embecta Corp – Dist abgegeben haben.

Stimmung

By Acuity

308 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.